The numerous pharmacologic options for patients with inflammatory bowel disease (IBD) can make treatment selection challenging, especially for healthcare professionals practicing in community settings. Tune in to this engaging video-based activity to: Explore the various factors that influence the choice of targeted therapy for each individual IBD patient Hear key insights from virtual ECHO sessions that recently took place at community clinics that treat IBD patients Explore a challenging real-life case presented and discussed at one of these sessions.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/expanding-ibd-treatment-capacity-community-gi-settings-targeted-treatment
- Start Date: 2025-03-07 06:00:00
- End Date: 2025-03-07 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Janssen (Any division) - Amount: 17500.0 - Is Kind Support: False Source: Takeda Pharmaceuticals (Any division) - Amount: 50000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest